Literature DB >> 10860207

Who should know about our genetic makeup and why?

T Takala1, H A Gylling.   

Abstract

Recent developments in biology have made it possible to acquire more and more precise information concerning our genetic makeup. Although the most far-reaching effects of these developments will probably be felt only after the Human Genome Project has been completed in a few years' time, scientists can even today identify a number of genetic disorders which may cause illness and disease in their carriers. The improved knowledge regarding the human genome will, it is predicted, in the near future make diagnoses more accurate and treatments more effective, and thereby considerably reduce and prevent unnecessary suffering. On the other hand, however, the knowledge can also be, depending on the case, futile, distressing or plainly harmful. This is why we propose to answer in this paper the dual question: who should know about our genetic makeup and why? Through an analysis of prudential, moral and legal grounds for acquiring the information, we conclude that, at least on the levels of law and social policy, practically nobody is either duty-bound to receive or entitled to have that knowledge.

Entities:  

Keywords:  Genetics and Reproduction

Mesh:

Year:  2000        PMID: 10860207      PMCID: PMC1733236          DOI: 10.1136/jme.26.3.171

Source DB:  PubMed          Journal:  J Med Ethics        ISSN: 0306-6800            Impact factor:   2.903


  3 in total

1.  Offering cystic fibrosis carrier screening to an HMO population: factors associated with utilization.

Authors:  E S Tambor; B A Bernhardt; G A Chase; R R Faden; G Geller; K J Hofman; N A Holtzman
Journal:  Am J Hum Genet       Date:  1994-10       Impact factor: 11.025

2.  What young people think and do when the option for cystic fibrosis carrier testing is available.

Authors:  J Mitchell; C R Scriver; C L Clow; F Kaplan
Journal:  J Med Genet       Date:  1993-07       Impact factor: 6.318

3.  Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms.

Authors:  D Malkin; F P Li; L C Strong; J F Fraumeni; C E Nelson; D H Kim; J Kassel; M A Gryka; F Z Bischoff; M A Tainsky
Journal:  Science       Date:  1990-11-30       Impact factor: 47.728

  3 in total
  6 in total

1.  Genetic ignorance and reasonable paternalism.

Authors:  T Takala
Journal:  Theor Med Bioeth       Date:  2001-09

2.  Overcritical, overfriendly? A dialogue between a sociologist and a philosopher on genetic technology and its applications.

Authors:  Mairi Levitt; Matti Häyry
Journal:  Med Health Care Philos       Date:  2005

Review 3.  Antenatal genetic testing and the right to remain in ignorance.

Authors:  R Bennett
Journal:  Theor Med Bioeth       Date:  2001-09

4.  Ethics, policy, and rare genetic disorders: the case of Gaucher disease in Israel.

Authors:  Michael L Gross
Journal:  Theor Med Bioeth       Date:  2002

5.  Is there a duty to remain in ignorance?

Authors:  Iain Brassington
Journal:  Theor Med Bioeth       Date:  2011-04

Review 6.  Ignorance, information and autonomy.

Authors:  J Harris; K Keywood
Journal:  Theor Med Bioeth       Date:  2001-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.